CVS Health Corporation (CVS)
CVS Health Stock Surges After Earnings Smash Forecasts. A Value Play Has Become a Rally.
The company boosts its full-year guidance range for adjusted earnings on the heels of a strong second quarter.
CVS Health Stock Soars on Strong Results, Raised 2025 Profit Outlook
Shares of CVS Health (CVS) jumped in premarket trading Thursday after the health care giant posted better-than-expected second-quarter results and lifted its full-year adjusted profit forecast.
CVS Health (CVS) Beats Q2 Earnings and Revenue Estimates
CVS Health (CVS) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.47 per share. This compares to earnings of $1.83 per share a year ago.
CVS beats estimates, hikes adjusted profit outlook on retail pharmacy and insurance unit strength
CVS Health reported second-quarter earnings and revenue that topped estimates and raised its adjusted profit outlook. CVS CEO David Joyner pointed to strength in its retail pharmacy business and some improvement in its insurance unit, Aetna, which is grappling with higher medical costs.
CVS Health reported earnings that beat Wall Street's expectations and upgraded its projection for 2025, as its health-insurance business showed signs of recovery
The healthcare giant's results underscore a split among insurers between those that are struggling and those that are beginning to revive.
Is CVS Health (CVS) Stock Outpacing Its Medical Peers This Year?
Here is how CVS Health (CVS) and Agenus (AGEN) have performed compared to their sector so far this year.
CVS Health Care Delivery: Will the Growth Momentum Last in Q2?
CVS' Health Care Delivery unit posts strong growth from Signify and Oak Street, but rising medical costs pose a near-term risk.
Buy CVS Stock Ahead of Its Upcoming Earnings?
CVS Health (NYSE:CVS) is scheduled to announce its earnings on Thursday, July 31, 2025. For event-driven traders, analyzing the stock's historical behavior around earnings releases can provide valuable context.
Thousands of Americans are being forced to switch from Zepbound to Wegovy as a result of new coverage restrictions by CVS Caremark. ‘I just wish they would trust my doctor.
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced better weight-loss results and fewer side effects.
Here's Why CVS Health (CVS) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
CVS Health (CVS) Stock Slides as Market Rises: Facts to Know Before You Trade
In the most recent trading session, CVS Health (CVS) closed at $58.75, indicating a -5.01% shift from the previous trading day.
CVS Health (CVS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
